Brain-Derived Neurotrophic Factor (BDNF)-induced Tropomyosin-related kinase B (Trk B) signaling is a potential therapeutic target for peritoneal carcinomatosis arising from colorectal cancer

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Tanaka, Koji ^a   Okugawa, Yoshinaga ^a   Toiyama, Yuji ^a   Inoue, Yasuhiro ^a   Saigusa, Susumu ^a   Kawamura, Mikio ^a   Araki, Toshimitsu ^a   Uchida, Keiichi ^a   Mohri, Yasuhiko ^a   Kusunoki, Masato ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; MESSENGER RNA; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN; MEMBRANE PROTEIN; PROTEIN TYROSINE KINASE; TROPOMYOSIN; TROPOMYOSIN-RELATED KINASE-B, HUMAN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANOIKIS; ARTICLE; CANCER PROGNOSIS; CARCINOMATOUS PERITONITIS; CELL INVASION; CELL MIGRATION; CELL VIABILITY; CHILD; COLORECTAL CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; OVERALL SURVIVAL; PERITONEUM METASTASIS; PROTEIN EXPRESSION; TUMOR GROWTH; ADOLESCENT; ANIMAL; BAGG ALBINO MOUSE; CACO 2 CELL LINE; CARCINOMA; CELL MOTION; CELL SURVIVAL; COLORECTAL TUMOR; GENETICS; HT 29 CELL LINE; METABOLISM; MIDDLE AGED; PERITONEUM TUMOR; SIGNAL TRANSDUCTION; TUMOR CELL LINE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CACO-2 CELLS; CARCINOMA; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; CHILD; COLORECTAL NEOPLASMS; HT29 CELLS; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MIDDLE AGED; PERITONEAL NEOPLASMS; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; TROPOMYOSIN; YOUNG ADULT;

EID: 84900446466     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096410     Document Type: Article

References (47)

1. Lucas AS, O'Neil BH, Goldberg RM (2011) A decade of advances in cytotoxic chemotherapy for metastatic colorectal cancer. Clin Colorectal Cancer. 10: 238-244.
2. Kerscher AG, Chua TC, Gasser M, Maeder U, Kunzmann V, et al. (2013) Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patients over two decades. Br J Cancer. 108: 1432-1439.
3. Bibel M, Barde YA (2000) Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev. 14: 2919-2937.
4. Arévalo JC, Wu SH (2006) Neurotrophin signaling: many exciting surprises! Cell Mol Life Sci. 63: 1523-1537. (Pubitemid 44156749)
5. Holgado-Madruga M, Moscatello DK, Emlet DR, Dieterich R, Wong AJ (1997) Grb2-associated binder-1 mediates phosphatidylinositol 3-kinase activation and the promotion of cell survival by nerve growth factor. Proc Natl Acad Sci U S A. 94: 12419-12424. (Pubitemid 27492543)
6. Nykjaer A, Willnow TE, Petersen CM (2005) p75NTR - live or let die. Curr Opin Neurobiol. 15: 49-57.
7. Hondermarck H (2012) Neurotrophins and their receptors in breast cancer. Cytokine Growth Factor Rev. 23: 357-365.
8. Verbeke S, Meignan S, Lagadec C, Germain E, Hondermarck H, et al. (2010) Overexpression of p75(NTR) increases survival of breast cancer cells through p21(waf1). Cell Signal. 22: 1864-1873.
9. Küchler J, Hartmann W, Waha A, Koch A, Endl E, et al. (2011) p75(NTR) induces apoptosis in medulloblastoma cells. Int J Cancer. 128: 1804-1812.
10. Li Z, Oh DY, Nakamura K, Thiele CJ (2011) Perifosine-induced inhibition of Akt attenuates brain-derived neurotrophic factor/TrkB-induced chemoresistance in neuroblastoma in vivo. Cancer. 117: 5412-5422.
11. Au CW, Siu MK, Liao X, Wong ES, Ngan HY, et al. (2009) Tyrosine kinase B receptor and BDNF expression in ovarian cancers - Effect on cell migration, angiogenesis and clinical outcome. Cancer Lett. 281: 151-161.
12. Lee J, Jiffar T, Kupferman ME (2012) A novel role for BDNF-TrkB in the regulation of chemotherapy resistance in head and neck squamous cell carcinoma. PLoS One.7:e30246.
13. Okamura K, Harada T, Wang S, Ijichi K, Furuyama K, et al. (2012) Expression of TrkB and BDNF is associated with poor prognosis in non-small cell lung cancer. Lung Cancer. 78: 100-106.
14. Lam CT, Yang ZF, Lau CK, Tam KH, Fan ST, et al. (2011) Brain-derived neurotrophic factor promotes tumorigenesis via induction of neovascularization: implication in hepatocellular carcinoma. Clin Cancer Res. 17: 3123-3133.
15. Ketterer K, Rao S, Friess H, Weiss J, Büchler MW, et al. (2003) Reverse transcription-PCR analysis of laser-captured cells points to potential paracrine and autocrine actions of neurotrophins in pancreatic cancer. Clin Cancer Res.9: 5127-5136. (Pubitemid 37413561)
16. Lai PC, Chiu TH, Huang YT (2010) Overexpression of BDNF and TrkB in human bladder cancer specimens. Oncol Rep. 24: 1265-1270.
17. Satoh F, Mimata H, Nomura T, Fujita Y, Shin T, et al. (2001) Autocrine expression of neurotrophins and their receptors in prostate cancer. Int J Urol.8:S28-34. (Pubitemid 34225134)
18. Pearse RN, Swendeman SL, Li Y, Rafii D, Hempstead BL (2005) A neurotrophin axis in myeloma: TrkB and BDNF promote tumor-cell survival. Blood.105: 4429-4436. (Pubitemid 40720791)
19. Vanhecke E, Adriaenssens E, Verbeke S, Meignan S, Germain E, et al. (2011) Brain-derived neurotrophic factor and neurotrophin-4/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survival. Clin Cancer Res. 17: 1741-1752.
20. Douma S, Van Laar T, Zevenhoven J, Meuwissen R, Van Garderen E, et al. (2004) Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature. 430: 1034-1039.
21. Smit MA, Geiger TR, Song JY, Gitelman I, Peeper DS (2009) A Twist-Snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasis. Mol Cell Biol. 29: 3722-37.
22. Bao W, Qiu H, Yang T, Luo X, Zhang H, et al. (2013) Upregulation of TrkB promotes epithelial-mesenchymal transition and anoikis resistance in endometrial carcinoma. PLoS One.8:e70616.
23. Tanaka K, Mohri Y, Nishioka J, Kobayashi M, Ohi M, et al. (2009) Neurotrophic receptor, tropomyosin-related kinase B as an independent prognostic marker in gastric cancer patients. J Surg Oncol. 99: 307-310.
24. Tanaka K, Mohri Y, Nishioka J, Ohi M, Yokoe T, et al. (2009) Neurotrophic receptor, tropomyosin-related kinase B, as a chemoresistant marker in oesophageal cancer. Clin Oncol (R Coll Radiol). 21: 362-363.
25. Fujikawa H, Tanaka K, Toiyama Y, Saigusa S, Inoue Y, et al. (2012) High TrkB expression levels are associated with poor prognosis and EMT induction in colorectal cancer cells. J Gastroenterol. 47: 775-784.
26. Okugawa Y, Tanaka K, Inoue Y, Kawamura M, Kawamoto A, et al. (2013) Brain-derived neurotrophic factor/tropomyosin-related kinase B pathway in gastric cancer. Br J Cancer. 108: 121-130.
27. Yu Y, Zhang S, Wang X, Yang Z, Ou G (2010) Overexpression of TrkB promotes the progression of colon cancer. APMIS. 118: 188-195.
28. Akil H, Perraud A, Mélin C, Jauberteau MO, Mathonnet M (2011) Fine-tuning roles of endogenous brain-derived neurotrophic factor, TrkB and sortilin in colorectal cancer cell survival. PLoS One. 6:e25097.
29. Sasahira T, Ueda N, Kurihara M, Matsushima S, Ohmori H, et al. (2013) Tropomyosin receptor kinases B and C are tumor progressive and metastatic marker in colorectal carcinoma. Hum Pathol. 44: 1098-1106.
30. Yang X, Martin TA, Jiang WG (2013) Biological influence of brain-derived neurotrophic factor (BDNF) on colon cancer cells. Exp Ther Med. 6: 1475-1481.
31. de Farias CB, Heinen TE, dos Santos RP, Abujamra AL, Schwartsmann G, et al. (2012) BDNF/TrkB signaling protects HT-29 human colon cancer cells from EGFR inhibition. Biochem Biophys Res Commun. 425: 328-332.
32. Brunetto de Farias C, Rosemberg DB, Heinen TE, Koehler-Santos P, Abujamra AL, et al. (2010) BDNF/TrkB content and interaction with gastrin-releasing peptide receptor blockade in colorectal cancer. Oncology.79: 430-439.
33. Desmet CJ, Peeper DS (2006) The neurotrophic receptor TrkB: a drug target in anti-cancer therapy? Cell Mol Life Sci. 63: 755-759. (Pubitemid 43724067)
34. Thiele CJ, Li Z, McKee AE (2009) On Trk - the TrkB signal transduction pathway is an increasingly important target in cancer biology. Clin Cancer Res. 15: 5962-5967.
35. Luberg K, Wong J, Weickert CS, Timmusk T (2010) Human TrkB gene: novel alternative transcripts, protein isoforms and expression pattern in the prefrontal cerebral cortex during postnatal development. J Neurochem. 113: 952-964.
36. Lommatzsch M, Braun A, Mannsfeldt A, Botchkarev VA, Botchkareva NV, et al. (1999) Abundant production of brain-derived neurotrophic factor by adult visceral epithelia. Implications for paracrine and target-derived Neurotrophic functions. Am J Pathol. 155: 1183-1193. (Pubitemid 29488926)
37. Lin CY, Chen HJ, Li TM, Fong YC, Liu SC, et al. (2013) β5 integrin upregulation in brain-derived neurotrophic factor promotes cell motility in human chondrosarcoma. PLoS One. 8:e67990.
38. Odate S, Nakamura K, Onishi H, Kojima M, Uchiyama A, et al. (2013) TrkB/BDNF signaling pathway is a potential therapeutic target for pulmonary large cell neuroendocrine carcinoma. Lung Cancer. 79: 205-214.
39. Bao W, Qiu H, Yang T, Luo X, Zhang H, et al. (2013) Upregulation of TrkB promotes epithelial-mesenchymal transition and anoikis resistance in endometrial carcinoma. PLoS One. 8:e70616.
40. Haapasalo A, Koponen E, Hoppe E, Wong G, Castrén E (2001) Truncated trkB.T1 is dominant negative inhibitor of trkB.TK+-mediated cell survival. Biochem Biophys Res Commun. 280: 1352-1358. (Pubitemid 32917793)
41. Carim-Todd L, Bath KG, Fulgenzi G, Yanpallewar S, Jing D, et al. (2009) Endogenous truncated TrkB.T1 receptor regulates neuronal complexity and TrkB kinase receptor function in vivo. J Neurosci. 29: 678-685.
42. Rose CR, Blum R, Pichler B, Lepier A, Kafitz KW, et al. (2003) Truncated TrkB-T1 mediates neurotrophin-evoked calcium signalling in glia cells. Nature. 426: 74-78. (Pubitemid 37432543)
43. Dorsey SG, Renn CL, Carim-Todd L, Barrick CA, Bambrick L, et al. (2006) In vivo restoration of physiological levels of truncated TrkB.T1 receptor rescues neuronal cell death in a trisomic mouse model. Neuron. 51: 21-28. (Pubitemid 43963340)
44. Li Z, Chang Z, Chiao LJ, Kang Y, Xia Q, et al. (2009) TrkBT1 induces liver metastasis of pancreatic cancer cells by sequestering Rho GDP dissociation inhibitor and promoting RhoA activation. Cancer Res. 69: 7851-7859.
45. Lemmens VE, Klaver YL, Verwaal VJ, Rutten HJ, Coebergh JW, et al. (2011) Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study. Int J Cancer. 128: 2717-2725.
46. Koppe MJ, Boerman OC, Oyen WJ, Bleichrodt RP (2006) Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg. 243: 212-222. (Pubitemid 43185440)
47. Russell AH, Pelton J, Reheis CE, Wisbeck WM, Tong DY, et al. (1985) Adenocarcinoma of the colon: an autopsy study with implications for new therapeutic strategies. Cancer. 56: 1446-1451. (Pubitemid 15230595)